Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer
Overexpression of DNA 5′-cytosine-methyltransferases (DNMT), which are enzymes that
methylate the cytosine residue of CpGs, is involved in many cancers. However, the …
methylate the cytosine residue of CpGs, is involved in many cancers. However, the …
Melatonin inhibits MMP‐9 transactivation and renal cell carcinoma metastasis by suppressing Akt‐MAPKs pathway and NF‐κB DNA‐binding activity
…, P Tan, YC Yang, WY Chen, SF Yang… - Journal of Pineal …, 2016 - Wiley Online Library
Renal cell carcinoma ( RCC ) is the most lethal of all urological malignancies because of its
potent metastasis potential. Melatonin exerts multiple tumor‐suppressing activities through …
potent metastasis potential. Melatonin exerts multiple tumor‐suppressing activities through …
Direct interaction of β‐catenin with nuclear ESM1 supports stemness of metastatic prostate cancer
KF Pan, WJ Lee, CC Chou, YC Yang, YC Chang… - The EMBO …, 2021 - embopress.org
Wnt/β‐catenin signaling is frequently activated in advanced prostate cancer and contributes
to therapy resistance and metastasis. However, activating mutations in the Wnt/β‐catenin …
to therapy resistance and metastasis. However, activating mutations in the Wnt/β‐catenin …
[HTML][HTML] High-entropy induced a glass-to-glass transition in a metallic glass
Glass-to-glass transitions are useful for us to understand the glass nature, but it remains
difficult to tune the metallic glass into significantly different glass states. Here, we have …
difficult to tune the metallic glass into significantly different glass states. Here, we have …
Roles of aldolase family genes in human cancers and diseases
YC Chang, YC Yang, CP Tien, CJ Yang… - Trends in Endocrinology & …, 2018 - cell.com
The aldolase family members involved in metabolism and glycolysis are present in three
isoforms: ALDOA, ALDOB, and ALDOC. Aldolases are differentially expressed in human tissues…
isoforms: ALDOA, ALDOB, and ALDOC. Aldolases are differentially expressed in human tissues…
[HTML][HTML] The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance
MS Weng, JH Chang, WY Hung, YC Yang… - Journal of Experimental …, 2018 - Springer
Background The epidermal growth factor receptor (EGFR) plays important roles in cell
survival, growth, differentiation, and tumorigenesis. Dysregulation of the EGFR is a common …
survival, growth, differentiation, and tumorigenesis. Dysregulation of the EGFR is a common …
[HTML][HTML] Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis
MH Chien, YW Lin, YC Wen, YC Yang, M Hsiao… - Journal of Experimental …, 2019 - Springer
Background Prostate cancer (PCa) is considered one of the most prevalent malignancy
globally, and metastasis is a major cause of death. Apigenin (API) is a dietary flavonoid which …
globally, and metastasis is a major cause of death. Apigenin (API) is a dietary flavonoid which …
Pyruvate kinase M2 promotes pancreatic ductal adenocarcinoma invasion and metastasis through phosphorylation and stabilization of PAK2 protein
TY Cheng, YC Yang, HP Wang, YW Tien, CT Shun… - Oncogene, 2018 - nature.com
Pyruvate kinase muscle isozymes (PKMs) have crucial roles in regulating metabolic
changes during carcinogenesis. A switch from PKM1 to PKM2 isoform was thought to lead to …
changes during carcinogenesis. A switch from PKM1 to PKM2 isoform was thought to lead to …
Nuclear translocation of PKM2/AMPK complex sustains cancer stem cell populations under glucose restriction stress
YC Yang, MH Chien, HY Liu, YC Chang, CK Chen… - Cancer letters, 2018 - Elsevier
Cancer cells encounter metabolic stresses such as hypoxia and nutrient limitations because
they grow and divide more quickly than their normal counterparts. In response to glucose …
they grow and divide more quickly than their normal counterparts. In response to glucose …
[HTML][HTML] AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway
Background Cisplatin is the first-line chemotherapy used against most upper aerodigestive
tract carcinomas. In head and neck cancer, sensitivity to cisplatin remains the key issue in …
tract carcinomas. In head and neck cancer, sensitivity to cisplatin remains the key issue in …